What is it about?

This study analyzed the correlation between various parameters obtained from multi-parametric magnetic resonance imaging (mpMRI) findings and traditional risk factors, such as prostate-specific antigen (PSA) and Gleason score (GS), in patients with prostate cancer (PCa). The study included 76 patients with a total of 84 detected lesions. The majority of lesions (82.14%) originated from the peripheral gland. The results showed correlations between PSA, GS, lesion size, apparent diffusion coefficient (ADC) values, and the Prostate Imaging Reporting and Data System (PI-RADS) score. Low tumor ADC values were associated with clinically significant tumors. Lesion size and PSA levels were higher in patients with clinically significant PCa. The study suggests that ADC values and lesion size could be used to differentiate between clinically significant and insignificant tumors. However, the PI-RADS score showed limited correlation with GS. The study highlights the potential of mpMRI parameters in risk classification and management of PCa patients.

Featured Image

Why is it important?

This study is important because it investigates the correlation between various parameters obtained from mpMRI and traditional risk factors in prostate cancer patients. Understanding the relationship between these factors can enhance the accuracy of risk classification and aid in the diagnosis, treatment, and follow-up of patients. It highlights the potential of mpMRI in providing valuable information for risk assessment, allowing for more personalized and effective management strategies for prostate cancer.

Read the Original

This page is a summary of: Evaluation of relationships between the final Gleason score, PI-RADS v2 score, ADC value, PSA level, and tumor diameter in patients that underwent radical prostatectomy due to prostate cancer, La radiologia medica, April 2020, Springer Science + Business Media,
DOI: 10.1007/s11547-020-01183-1.
You can read the full text:

Read

Contributors

The following have contributed to this page